Q1 2023 · 13F-HR
Bill & Melinda Gates Foundationholdings as filed
Filed 2023-05-12 · accession 0000898432-23-000302
$113.2M
Reported value
9
Positions
2023-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $36.3M | 32.0% | 1,559,142 | Common | SOLE |
| 45258D105 | IMCR | IMMUNCORE HLDGS PLC | $28.5M | 25.2% | 576,923 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $18.5M | 16.4% | 148,674 | Common | SOLE |
| N2451R105 | CVAC | CUREVAC N V | $11.3M | 10.0% | 1,625,943 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA | $8.4M | 7.45% | 1,590,909 | Common | SOLE |
| G5709L109 | — | LUMIRADX LTD | $6.7M | 5.93% | 14,285,714 | Common | SOLE |
| 124155102 | BFLY | BUTTERFLY NETWORK INC | $1.9M | 1.68% | 1,011,003 | Common | SOLE |
| 04965G109 | BCELUSD | ATRECA INC | $1.1M | 1.01% | 1,006,579 | Common | SOLE |
| 03236M200 | — | AMYRIS INC | $397,661 | 0.35% | 292,398 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.